BosPro 500 mg
Product Information
- Brand
- EuroMedica
- Form
- Softgel Capsule
- Servings Per Container
- 60
- UPC
- 3 67703 84306 9
- Product Type
- Botanical
- DSLD Entry Date
- 2024-01-24
Target Groups
Label Statements
Formula re: Contains
Boswellia, also known as frankincense, has been a vital component of Ayurvedic medicine for thousands of years. Modern research has confirmed the effectiveness of boswellia for healthy lung and bronchial function, as well as intensive intestinal support.
Formula re: Contains
Features clinically studied, uniquely standardized BosPure Boswellia Contains boswellia with high levels of naturally occurring AKBA - no spiking or artificial manipulation to increase this beneficial compound.
Formulation re: Other
Extra strength for advanced support; up to 10 times more powerful than unstandardized boswellia Purified to reduce undesirable beta-boswellic acid (BBA) content
Suggested/Recommended/Usage/Directions
Recommendations: 1 softgel daily, or as recommended by your healthcare practitioner.
Precautions re: Pregnant or Nursing or Prescription Medications
If pregnant or nursing, consult a healthcare practitioner before use.
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Formula re: Contains
Boswellia for advanced lung, bronchial, and intestinal support Cliinically studied BosPure boswellia
FDA Statement of Identity
Dietary Supplement
Formulation re: Does NOT Contain
No sugar, salt, soy, yeast, wheat, gluten, corn, dairy products, artificial flavoring, or artificial preservatives. Non-GMO
Brand IP Statement(s) re: (c), (TM), (SM)
BosPure is a registered trademark of Dolcas-Biotech
Supplement Facts Panel
* Percent Daily Values are based on a 2,000 calorie diet.
† Daily Value not established.